BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125

BTIG analyst Justin Zelin maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $125.According to TipRanks data, the analyst has a success rate of 37.8% and a t

Futu NewsJul 4 21:31 · Ratings

Optimistic Outlook for Viking Therapeutics' Obesity Treatments Amid Upcoming Catalysts and Regulatory Progress

TipRanksJul 4 21:15

A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.

A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.

Zhitong FinanceJul 4 14:42

S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?

The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June's sharply lower-than-expected services sector activ

BenzingaJul 4 01:04

Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $110

Jefferies analyst Roger Song maintains $Viking Therapeutics(VKTX.US)$ with a buy rating, and maintains the target price at $110.According to TipRanks data, the analyst has a success rate of 29.1% and

Futu NewsJul 3 20:31 · Ratings

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)

TipRanksJul 3 20:11